Wilson Sonsini Goodrich & Rosati is pleased to sponsor LaunchBio’s Larger Than Life Science Series: Accelerating Early Discovery Research, Navigating Challenges and Mitigating Risk. Building infrastructure to support research is expensive, time-consuming, and may not be the right approach for early research work. What are the alternatives? This panel discussion will bring to light flexible options available to researchers in the Bay Area to support emerging or well-established biotech and pharmaceutical companies looking to expand while staying nimble, and academics looking for low-cost solutions to help them start their biotech journey.
Lori Doyle
ldoyle@wsgr.comGeorgia Ravitz is a partner in the life sciences practice of Wilson Sonsini Goodrich & Rosati, where she specializes in FDA regulatory, healthcare, and consumer products innovation and compliance. In particular, she focuses on food and drug law and regulatory policy governing the regulation and promotion of medical devices, pharmaceuticals (including OTCs), health and beauty aids (cosmetics), dietary supplements, vitamins, food and agribusiness, tobacco and e-cigarettes, cannabis, and a wide variety of consumer goods and emerging consumer technologies. She counsels U.S. and foreign manufacturers, distributors, retailers, and importers of regulated products in all phases of their product lifecycle, from innovation through product commercialization and ongoing post-market compliance.